E2F8 and central nervous system cancer: Yu et al. investigated the expression of E2Fs and their prognostic value in high-grade glioma based on the TCGA dataset and identified E2F7 and E2F8 as novel potential prognostic markers linked with aggressive oncogenic processes [39].